Bedside Transcatheter Patent Ductus Arteriosus Device Occlusion in an Extremely Low Birth Weight Neonate: A Novel Approach in a High-Risk Population.
Bedside Transcatheter Patent Ductus Arteriosus Device Occlusion in an Extremely Low Birth Weight Neonate: A Novel Approach in a High-Risk Population.
复制标题
DOI：
10.1155/2021/4716997
复制
发表时间：
2021
影响因子：
--
通讯作者：
Lubin L
中科院分区：
文献类型：
--
作者：
Pouldar TM;Wong R;Almeida-Jones M;Zahn E;Lubin L
体重小于1公斤的极低出生体重儿（ELBW）是动脉导管未闭（PDA）延迟闭合的高危人群。经皮动脉导管未闭封堵术与外科动脉导管未闭封堵术相比，是一种侵入性更小的方法，可提供更快的恢复时间和更少的输血需求。然而，该过程涉及将虚弱、不稳定的患者从新生儿重症监护室（NICU）运送到导管插入实验室，这为新生儿带来了许多潜在风险。在床旁进行经皮PDA闭合术是在导管室进行手术的成功替代方案，并避免了与转运ELBW新生儿相关的风险。
Extremely low birth weight (ELBW) infants weighing less than 1 kilogram are at a high-risk for delayed patent ductus arteriosus (PDA) closure. Percutaneous PDA closure offers a less invasive approach when compared with surgical PDA closure, which may provide faster recovery times and less transfusion requirements. However, this procedure involves transporting tenuous, unstable patients from the neonatal intensive care unit (NICU) to the catheterization laboratory which introduces many potential risks for the neonate. Performing percutaneous PDA closure at the bedside offers a successful alternative to performing the procedure in the catheterization laboratory and avoiding risk associated with transporting ELBW neonates.